We only have this paper's title and publication details.
Read it at the sourceResearch demonstrates RGN6024 improves viability in microglial cells, indicating its potential for glioblastoma therapy.
The effect of RGN6024 on the viability of non-tumorigenic microglial cells
No takes yet. Share an insight, caveat, or question.
Patrón et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: